Truveta Research Highlights Gaps in IUD Pain Management Practices Using Large-Scale EHR Data

According to a recent LinkedIn post from Truveta, Truveta Research has published a study in the journal Contraception examining pain management practices for intrauterine device (IUD) insertion across the U.S. The post indicates that, using electronic health record data from more than 286,000 IUD insertions between 2018 and 2025, the researchers found that 95% of patients in 2025 had no documented lidocaine or opioid use on the day of the procedure, even after updated CDC guidance addressing pain management. While the study reportedly shows a modest increase in documented use of pain-relief medications following the guidance, overall utilization appears to remain low, suggesting a substantial gap between clinical recommendations and real-world practice.

For investors, this type of outcomes-focused research underscores Truveta’s ability to leverage large-scale EHR datasets to generate clinically relevant insights. Demonstrating that its data platform can identify discrepancies between guideline-based care and actual practice may strengthen Truveta’s value proposition to life sciences companies, providers, and payers seeking real-world evidence. If the company can continue to convert such studies into commercial partnerships or subscription-based analytics offerings, it could enhance revenue visibility and reinforce its positioning in the healthcare data and analytics market. Additionally, publication in a peer-reviewed journal may support the credibility of Truveta’s research capabilities, which is a key consideration for potential enterprise customers and collaborators.